SFL – Third Quarter 2021 Results Presentation
Please find enclosed the presentation of the preliminary third quarter results to be held November 10, 2021, in the link below.AttachmentSFL – Third Quarter 2021 Results Presentation
Year: 2021
Navios Maritime Partners L.P. Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2021
Revenue:$228.0 million for Q3 2021
$445.0 million for 9M 2021Net cash from operating activities:$70.9 million for Q3 2021
$148.2 million for 9M 2021Net Income:$162.1 million for Q3 2021
$398.6 million for 9M 2021 Adjusted EBITDA:$145.2 million for Q3 2021
$269.8 million for 9M 2021Merger with Navios Maritime Acquisition Corporation completed on October 15, 2021Entry in crude and product tankers segments163% increase in number of vessels year-to-dateSecured long-term time charters for 10 containerships~$690 million contracted revenue$0.05 per unit cash distribution for Q3 2021MONACO, Nov. 10, 2021 (GLOBE NEWSWIRE) — Navios Maritime Partners L.P. (“Navios Partners”) (NYSE: NMM), an international owner and operator of dry cargo and tanker vessels, today reported its financial...
Volaris Group Continues to Expand in Healthcare Vertical with Acquisition of Hospedia Limited
TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) — Volaris Group Inc. (“Volaris”) has announced that it has acquired Hospedia Limited (“Hospedia”) based in Pontefract, United Kingdom. Hospedia, a leading provider of point of care software and services to the UK’s NHS Trusts, joins a growing number of Volaris businesses headquartered in the UK and significantly expands Volaris’ footprint in the healthcare vertical.
“It’s a very exciting time to join the Volaris Group healthcare portfolio,” said Rob Turner, Group Leader at Volaris. “Our businesses are leveraging Volaris best practices and growing through acquisition which is enabling them to serve their customers in new and exciting ways. More importantly, when we do that, we are truly making a difference to the lives of patients and those who care for them.”
Hospedia will be managed by WiFi...
Pharvaris Reports Third Quarter 2021 Financial Results and Provides Business Highlights
RAPIDe-1, Phase 2 on-demand study of PHVS416 for the treatment of HAE attacks, proceeding; topline data reaffirmed for 2022
CHAPTER-1, Phase 2 prophylactic study of PHVS416 for the prevention of HAE attacks, recruiting; topline data expected in 2022
PHVS719 Phase 1 pharmacokinetics study initiating this month
Executing from a strong financial position with cash and cash equivalents of €218.6 million as of September 30, 2021ZUG, Switzerland, Nov. 10, 2021 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization of novel oral bradykinin-B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin-B2-receptor-mediated indications, today reported financial results for the third quarter ended September 30, 2021, and provided an update...
EDAP TMS SA to Announce Third Quarter 2021 Financial Results on Wednesday, November 17, 2021
Company to host conference call and webcast on Thursday, November 18, at 8:30 am ET
LYON, France, November 10, 2021 – EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter ended September 30, 2021 after the markets close on Wednesday, November 17, 2021.
An accompanying conference call and webcast will be conducted by Marc Oczachowski, Chairman of the Board and Chief Executive Officer, Ryan Rhodes, Chief Executive Officer of EDAP U.S.A., and François Dietsch, Chief Financial Officer. The call will be held at 8:30am ET on Thursday, November 18, 2021. Please refer to the information below for conference call dial-in information and webcast registration.
Conference Call & WebcastThursday, November 18th@ 8:30am Eastern TimeDomestic: 877-451-6152International: ...
Levitee Labs Signs Letter of Intent to Acquire a Chain of Specialty Addiction Pharmacies Located in British Columbia
Signed LOI to acquire 100% interest in chain of specialty addiction pharmacies in Vancouver, BC
Acquisition price of $4.0 million based upon approximately 4.7x trailing 6 months annualized EBITDA of $850,000
The chain operates 3 locations, which will be added to the Levitee Pharmacies growing portfolio of locations throughout Alberta and British ColumbiaVANCOUVER, British Columbia, Nov. 10, 2021 (GLOBE NEWSWIRE) — Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE: 7H7) (the “Company” or “Levitee”), an integrative wellness company with a diversified portfolio of healthcare and wellness assets, has signed a letter of intent (“LOI”) to acquire 100% of the issued and outstanding shares in a company owning and operating a chain of specialty addiction pharmacies located throughout the lower mainland of British Columbia,...
Level Home, Inc. Acquires and Merges with Dwelo, Inc., Secures $100+M Series C
The combination of Level’s industry-defining smart access hardware with Dwelo’s smart device platform launches a new era for the connected home experience across all owned, shared, and rented residential properties
REDWOOD CITY, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) — Level Home Inc., the company redefining the smart home experience, today announced that it has acquired and merged with Dwelo, Inc., the leading provider of SaaS-based smart device management platforms for multifamily properties. With the addition of Dwelo, Level now offers a world-class smart home platform of integrated hardware and software solutions for all residential properties, including both single-family and multifamily units.
Dwelo’s software and service platform, the multifamily industry’s first, enables owners to offer smart home experiences to their residents,...
UNITY Biotechnology, Inc. Reports Third Quarter 2021 Financial Results and Business Updates
UBX1325 Phase 2 study in DME currently enrolling, with additional Phase 2 study in AMD planned for 1H22
UNITY to present at invitation-only Eyecelerator innovation conference at AAO
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the third quarter ended September 30, 2021.
“In our Phase 1 clinical study, UBX1325, a senolytic small molecule working through an entirely new mechanism of action, has shown a favorable safety profile and very promising evidence of biological activity through six months, demonstrating durability,” said Anirvan Ghosh, Ph.D., chief executive officer of UNITY. “As announced yesterday, we share the excitement of the...
Rain Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Progress
New Phase 2 clinical trial planned for milademetan in Merkel cell carcinoma (MCC), the MANTRA-3 trial, to start in mid-2022
Quarter-end cash position of $150.1 million provides runway to advance research and development (R&D) pipeline and complete all three planned clinical trials of milademetan
Management to host conference call and webcast today at 4:30PM Eastern Time
NEWARK, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (Rain), a late-stage company developing precision oncology therapeutics, today reports financial results for the third quarter and nine months ended September 30, 2021, along with an update on the company’s key developments, business operations and upcoming milestones.
“Rain has had a number of important recent accomplishments including data presentations at various...
QuoteMedia Announces 22% Revenue Growth for Q3 2021
PHOENIX, Nov. 10, 2021 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, announced financial results for the quarter ended September 30, 2021.
QuoteMedia provides banks, brokerage firms, private equity firms, financial planners and sophisticated investors with a more economical, higher quality alternative source of stock market data and related research information. We compete with several larger legacy organizations and a modest community of other smaller companies. QuoteMedia provides comprehensive market data services, including streaming data feeds, on-demand request-based data (XML/JSON), web content solutions (financial content for website integration) and applications such as Quotestream Professional desktop and mobile.
Highlights for Q3 2021 include the following:Quarterly...
